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Abstract
The molecular pathways regulating lymphoid priming, fate, and development of multipotent bone 
marrow hematopoietic stem and progenitor cells (HSPCs) that continuously feed thymic 
progenitors remain largely unknown. While Notch signal is indispensable for T cell specification 
and differentiation, the downstream effectors are not well understood. PRL2, a protein tyrosine 
phosphatase that regulates hematopoietic stem cell proliferation and self-renewal, is highly 
expressed in murine thymocyte progenitors. Here we demonstrate that protein tyrosine 
phosphatase PRL2 and receptor tyrosine kinase c-Kit are critical downstream targets and effectors 
of the canonical Notch/RBPJ pathway in early T cell progenitors. While PRL2 deficiency resulted 
in moderate defects of thymopoiesis in the steady state, de novo generation of T cells from Prl2 
null hematopoietic stem cells (HSCs) was significantly reduced following transplantation. Prl2 
null HSPCs also showed impaired T cell differentiation in vitro. We found that Notch/RBPJ 
signaling upregulated PRL2 as well as c-Kit expression in T cell progenitors. Further, PRL2 
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sustains Notch-mediated c-Kit expression and enhances SCF/c-Kit signaling in T cell progenitors, 
promoting effective DN1-DN2 transition. Thus, we have identified a critical role for PRL2 
phosphatase in mediating Notch and c-Kit signals in early T cell progenitors.
Graphical abstract
Cooperation of PRL2 phosphatase with Notch and c-Kit signals is critical for early T cell 
differentiation. Delta/Notch engagement induces the expression of both c-Kit and PRL2 in ETPs. 
PRL2 then sustains and/or potentiates Kit signaling to facilitate DN1-DN2 transition. In the 
absence of PRL2, c-Kit expression is decreased and decreased c-Kit expression promotes ETP 
differentiation toward myeloid lineages. Thus, sustaining high level of c-Kit expression by PRL2 
is crucial for ETP expansion, survival, and commitment during early stage T cell development.
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INTRODUCTION
The thymic microenvironment supports the differentiation and proliferation of the bone 
marrow-derived progenitors as they enter and migrate through the thymus [1–2]. The 
lymphoid-primed multipotent progenitors (LMPPs) are thought to be the thymus-seeding 
progenitors (TSPs) that differentiate into early T lineage progenitors (ETPs) [1–2]. ETPs 
share fundamental characteristics with bone marrow progenitors, such as high expression of 
the cell-surface markers c-Kit and CD44, the absence of markers of mature cells and 
multilineage developmental potential. After arriving in the thymus, ETPs lose the potential 
to generate B cells, whereas their potential to develop into myeloid cells, natural killer cells 
and dendritic cells is retained at the CD4−CD8− double-negative 2a (DN2a) stage [1–2]. 
ETPs express high levels of receptor tyrosine kinase c-Kit that persists in DN2a cells but is 
gradually downregulated in DN2b/DN3 cells, where final T cell commitment is 
accomplished by the expression of a number of transcription factors, including GATA3 and 
Bcl11b [3–6].
C-Kit plays a critical role in maintaining postnatal T lymphopoiesis in thymus [3–7]. Mice 
lacking c-Kit (c-Kitw/w) displayed age-dependent accumulation of DN1 cells and had 
massive reduction of DN2 to CD4+CD8+ double-positive (DP) cells in the thymus [5]. Mice 
with partial loss-of-function (LOF) c-Kit mutations also showed similar T cell phenotypes. 
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In vivo and in vitro studies that utilized c-Kit inhibitors demonstrated that c-Kit was critical 
for early thymocyte development [7–10]. Although c-Kit is critically important for post-
transplant T cell reconstitution, it is dispensable for post-transplant B cell and myeloid cell 
formation [11–12], indicating that T cell generation is more dependent on c-Kit activity than 
other lineages. While it has been postulated that the severe hematopoietic defects seen in Kit 
mutant mice may be due to cumulative effects from HSCs to progenitors [11–13], the role of 
c-Kit signaling in ETPs is largely unknown.
Delta/Notch association is one of the most important signals provided by the thymic 
environment to initiate T cell differentiation [1–2]. Although molecular mechanisms of early 
T cell differentiation have been extensively investigated, the downstream effectors of Notch 
signaling require further clarification. Given that Notch activation is essential for T-lineage 
specification of lymphomyeloid progenitors seeding the thymus [1] and that progression 
along T cell lineage further requires cooperative signaling provided by SCF and receptor 
tyrosine kinase c-Kit, it is important to delineate how Notch activation links to SCF/c-Kit 
signaling in T cell progenitors [14].
The phosphatase of regenerating liver (PRL) family of phosphatases, consisting of PRL1, 
PRL2, and PRL3, represents an intriguing group of proteins being validated as biomarkers 
and therapeutic targets in human cancer [15–17]. We have been investigating the role of 
PRL2 in development and cancer [18–21]. We generated Prl2 deficient mice and found that 
PRL2 is required for extra-embryonic development and associates the oncogenic properties 
of PRL2 with its ability to negatively regulate PTEN, thereby activating the PI3K-Akt 
pathway [18]. To determine the role of PRL2 in hematopoiesis, we analyzed HSC behavior 
in Prl2 deficient mice. We found that Prl2 deficiency impairs HSC self-renewal as revealed 
by serial bone marrow transplantation assays [19–20]. Moreover, we observed that Prl2 null 
hematopoietic stem and progenitor cells (HSPCs) are more quiescent and show reduced 
activation of the AKT and ERK signaling. While stem cell factor (SCF) is an early acting 
cytokine that activates the receptor tyrosine kinase KIT and promotes HSC maintenance, 
how SCF/KIT signaling is regulated in hematopoietic stem and progenitor cells is poorly 
understood. We found that PRL2 is important for SCF-mediated HSPC proliferation and loss 
of PRL2 decreased the ability of oncogenic KIT/D814V mutant in promoting hematopoietic 
progenitor cell proliferation. Thus, PRL2 plays critical roles in regulating HSC self-renewal, 
at least in part, through mediating SCF/KIT signaling [19–20]. We also found that PRL2 
deficiency impairs Kit signaling and spermatogenesis [21]. Thus, the defects seen in PRL2-
deficient hematopoietic and testis spermatogonia cells recapitulate some phenotypes of c-Kit 
mutant mice [3–7], suggesting that PRL2 may regulate SCF/c-Kit signaling during 
development [19–21].
Here we report a functional requirement for PRL2 in T cell development. We observed that 
PRL2 is highly expressed in early stage thymic progenitors. While PRL2 deficiency resulted 
in moderate defects of thymopoiesis in the steady state, de novo generation of T cells from 
Prl2 null HSCs was significantly reduced following transplantation. Prl2 null HSPCs also 
showed impaired T cell differentiation in vitro. We found that Notch/RBPJ signaling 
upregulated PRL2 as well as c-Kit expression in T cell progenitors. We further discovered 
that PRL2 enhanced SCF/c-Kit signaling in T cell progenitors, promoting efficient DN1 to 
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DN2 transition. Thus, we have identified a critical role for the PRL2 phosphatase in 
mediating Notch and c-Kit signals during T cell development.
MATERIALS AND METHODS
Mice
Wild type C57BL/6 (CD45.2+), B6.SJL (CD45.1+), and F1 mice (CD45.2+ CD45.1+) mice 
were purchased from the Jackson Laboratories. Prl2−/−, RBPJflox/flox-Mx1-cre+, and wild 
type mice were maintained in the Indiana University Animal Facility according to IACUC-
approved protocols, and kept in Thorensten units with filtered germ-free air. All mice were 
7–12 weeks of age at the time of analysis.
Flow cytometry
Flow cytometry analysis of hematopoietic stem and progenitor cells was performed as 
described previously [18]. Briefly, hematopoietic cells isolated from bone marrow, thymus, 
or spleen were stained on ice for 30 min with the Biotin-conjugated lineage markers and 
then were stained with fluorochrome-conjugated antibodies. Definition of each stem and 
progenitor population is shown in Supplementary Table 1. Flow antibodies were purchased 
from Biolegend, eBioscience or BD Bioscience (listed in Supplementary Table 2). 
Experiments were performed on FACSAria and FACSLSR II cytometers (BD Biosciences) 
and analyzed by using the FlowJo Version 9.3.3 software (TreeStar).
Real-time PCR
For quantitative reverse-transcription polymerase chain reaction (RT-PCR), total RNA was 
isolated using the RNeasy Plus Micro Kit (QIAGEN), and then subjected to reverse 
transcription with random hexamers (SuperScript III kit; Invitrogen). Quantitative real-time 
PCR was performed with SYBR Green (Qiagen) on an ABI PRISM 7500 system. Gene 
specific primers were designed to flank introns so that products from cDNA could be 
distinguished from possible genomic DNA contamination. Primer sequences are listed in 
Supplementary Table 3.
In vitro methylcellulose colony-forming cell assay
Clonogenic progenitors were determined in methylcellulose medium (MethoCult GF 
M3234, StemCell Technologies) with cytokines (SCF, TPO, EPO, IL-3, and GM-CSF) using 
2 x 104 BMMCs per well (6-well plate). Colonies were scored after 7 days of the culture.
Apoptosis assays
Thymocytes were harvested and cultured in the presence of IL-7 (5ng/ml) for 48hrs with or 
without 2Gy irradiation. Cell viability was evaluated by PI/Annexin V staining in 
combination with lineage markers, including CD25, CD44, and CD117.
In vitro T-cell differentiation assays
OP9-DL1 cells were maintained and cultured as previously described [22]. Sorted 200 of 
KSLs or 1x105 of DN3 cells from Prl2+/+ and Prl2−/− mice were cultured with OP9-DL1 
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cells in the presence of IL-7 (10 ng/ml). The fusion proteins Delta-like1/Fc or Jagged1/Fc 
(R&D) were coated onto 96 well plate at the concentration of 5 ng/ml or 20 ng/ml 
respectively [23]. Sorted LMPPs, ETPs, or DN2 cells were also applied onto coated plate in 
the presence of Flt3 ligand (10ng/ml), IL-7 (10ng/ml) and graded dose of SCF (0.2 to 25 ng/
ml). Cells were harvested for measuring cell proliferation and differentiation.
Transplantation assays
Bone marrow mononuclear cell and HSC transplantation assays were performed as 
described previously [18]. Briefly, we injected 200 CD48−CD150+KSL cells from wild type 
or Prl2 null mice (CD45.2+) plus 3 × 105 competitor bone marrow cells (CD45.1+) into 
lethally irradiated F1 mice (CD45.1+CD45.2+).
Production of Retrovirus
Retroviral particles were produced by transfection of Phoenix E cells with the MSCV-IRES-
GFP or MSCV-Notch-ICN1-IRES-GFP plasmids, according to standard protocols. Mouse 
hematopoietic progenitor cells were infected with high-titer retroviral suspensions in the 
presence of retronectin. Twenty-four hours after infection, the GFP positive cells were sorted 
by FACS.
Luciferase assay
293 cells were transfected with human PRL2 promoter driven luciferase reporter plasmids 
containing either RBPJ binding sites or mutant RBPJ binding sites. Luciferase activity was 
assayed 24 hours after transfection according to manufacturer’s instructions (Promega).
Statistical Analysis
We used either Student’s t test or two-way analysis of variance to determine statistical 
significance. *, P<0.05; **, P<0.01; ***, P<0.001; ns, not significant.
RESULTS
PRL2 deficiency alters postnatal thymopoiesis
To determine the role of PRL2 in T cell development, we examined the spleen and thymus 
of Prl2+/+ and Prl2−/− mice. PRL2 deficiency resulted in marked reduction of splenocyte and 
thymocyte counts compared to that of the Prl2+/+ mice (Fig. 1A). Although both T cell and 
B cell generation were normal in Prl2−/− spleen (Supplementing information Fig. S1A), T 
cell production is altered in Prl2−/− thymus. While the frequency of DN cells in Prl2−/− 
thymus was increased, the frequency of DP cells was decreased (Fig. 1B). The absolute 
number of DN4 and DP cells was lower in Prl2−/− thymus than that of the Prl2+/+ thymus 
(Fig. 1C). Within DN cells, the frequency of DN2a, DN2b, and DN3 was higher in Prl2−/− 
thymus than that of the Prl2+/+ thymus, whereas the frequency of DN1 and ETP was 
comparable (Supplementing information Fig. S1B). Prl2−/− thymus showed higher 
frequency of Gr1+ myeloid cells and B220+ cells compared to Prl2+/+ thymus 
(Supplementing information Fig. S1C). To determine the impact of PRL2 deficiency on 
thymic microenvironment, we examined SCF and DLL expression in stromal cells from 
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Prl2+/+ and Prl2−/− thymus. We found that the expression of SCF and DLL were comparable 
in Prl2+/+ and Prl2−/− cells (Supplementing information Fig. S1D), suggesting that Prl2−/− 
thymic microenvironment is normal. We also found comparable numbers of lymphoid-
primed multipotent progenitors (LMPPs) and common lymphoid progenitors (CLPs) in both 
Prl2+/+ and Prl2−/− bone marrow (Supplementing information Fig. S1E). Given that PRL2 is 
important for HSPC proliferation [18], we measured the cell cycle status of T cell 
progenitors and found that Prl2−/− DN2a and DN2b cells were more quiescent than Prl2+/+ 
cells (Fig. 1D). Prl2−/− T cell progenitors did not show increased apoptosis in the presence 
or the absence of irradiation in vitro (Fig. 1E). Thus, PRL2 deficiency specifically alters 
postnatal thymopoiesis.
PRL2 deficiency impairs T cell development following HSC transplantation
Given that c-Kit loss-of-function (LOF) bone marrow cells show decreased T cell 
reconstitution following transplantation [11–13], we evaluated T cell development in 
recipient mice repopulated with Prl2+/+ or Prl2−/− BM cells. In competitive transplantation 
assays, Prl2−/− BM cells showed significantly reduced T cell production in recipient thymus 
compared to Prl2+/+ cells at 18 weeks following transplantation (Fig. 2A). Next, we 
performed HSC transplantation and found that Prl2−/− HSCs showed markedly reduced T 
cell production in the peripheral blood (PB) of recipient mice compared to that of the Prl2+/+ 
cells (Fig. 2B), indicating that the de novo T cell generation from HSCs was impaired. The 
number of donor-derived CD3+ cells in the PB of recipient mice repopulated with Prl2−/− 
HSCs was 30-fold less than that of the Prl2+/+ cells (Fig. 2C). While the absolute number of 
Prl2−/− HSCs in the femurs of the recipient mice was 6-fold lower than that of the Prl2+/+ 
HSCs, the T cell defect in the peripheral blood of recipient mice repopulated with Prl2−/− 
HSCs was more dramatic than B cell or myeloid cell defect (Fig. 2C). Donor cell 
engraftment in the recipient thymus was similar to our observation in PB (Prl2+/+: 91±6.7 
vs. Prl2−/−: 4.6±0.3 %, ***p<0.0001); however, Prl2−/− HSCs showed robust ETP 
chimerism (60%), which was much higher than overall thymocyte chimerism and close to 
that of the Prl2+/+ cells (91.8±10.1 vs. 59.6±13.5%) (Fig. 2D and S2A). Subsequently, 
Prl2−/− HSCs showed decreased DN2 production, which was less than 10% (Supplementing 
information Fig. S3A). Consistent with our observations in the thymus, T cell production in 
the recipient spleen repopulated with Prl2−/− HSCs was lower than that of the Prl2+/+ cells 
(Supplementing information Fig. S3B). We also calculated the frequency of donor-derived T 
cell progenitor populations for each developmental stage. The frequency of Prl2+/+ ETPs 
was approximately 0.01%, and the frequency of other T cell progenitor cell population was 
increased during T cell differentiation. However, the frequency of ETP derived from Prl2−/− 
HSCs was 30-fold higher than that of the Prl2+/+ cells (Fig. 2E and 2F). The frequency of 
DN2 and DN3 cells derived from Prl2−/− HSCs was moderately increased (Fig. 2E and 2F), 
indicating that the DN1 to DN2 transition requires PRL2.
PRL2 deficiency impairs T cell development in vitro
Next, we investigated the effect of PRL2 deficiency on in vitro T cell generation utilizing 
both the Delta-Like1 (DLL1) expressing OP9 (OP9-DL1) stromal cells [22] and the feeder-
free T cell culture system with Delta-like1-Fc fusion protein (DLL1-Fc) [23]. When sorted 
KSL cells were cultured on OP9-DL1 cells, the number of cumulative produced cells from 
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500 Prl2−/− KSLs was reduced up to 100 fold compared to that of the Prl2+/+ cells (Fig. 3A). 
The total double positive (DP) cell count was also significantly decreased in the Prl2−/− 
group compared to the Prl2+/+ group (Fig. 3B), demonstrating that PRL2 is critical for T cell 
expansion in vitro. To determine the stage specificity, we cultured KSLs or DN3 cells on 
OP9-DL1 cells and then harvested all cells for flow cytometry analysis. After 14 days of 
culture, Prl2−/− KSLs showed reduced ETP production compared to Prl2+/+ KSLs (Fold 
increase: 184±14 vs. 12.5±4.3, ****p<0.0001; Fig. 3C). Prl2−/− KSLs showed reduced DN1 
production as well (data not shown). While DN1 contains heterogeneous cells with varied T 
cell differentiation capacities [24], we found that KSLs from either genotype generated 
comparable number of non-ETP DN1 cells (17.1±6.1 vs. 7.1±1.2, p=0.05; Fig. 3C). When 
Prl2−/− DN3 cells were plated onto OP9-DL1 cultures, we observed moderate decrease in 
cell expansion compared to Prl2+/+ cells (Fold increase: 4.8±0.2 vs. 3.2±0.3, **p<0.01; Fig. 
3D), suggesting that PRL2 specifically regulates early T cell lineage development.
Although early stage T cell differentiation depends on c-Kit [9–10], there is no direct 
evidence that bone marrow cells from c-Kit mutant mice show defective T cell 
differentiation in vitro. To determine the effect of SCF on T cell differentiation in vitro, we 
utilized the feeder-free T-cell culture system with DLL1-Fc [23]. When purified Prl2+/+ 
LMPPs were cultured on DLL1-Fc (R&D Systems)-coated plate in the presence of graded 
dose of SCF, total cells generated were increased in a SCF dosage-dependent manner (Fig. 
3E). While SCF promoted differentiation of LMPPs toward the DN2/3 stage, even at low 
doses (1 ng/ml), the fold increase was small (Supplementing information Fig. S4A and 
S4B). T cell differentiation was also accompanied by increased myeloid differentiation 
(Supplementing information Fig. S4A). In contrast, Prl2−/− LMPPs, ETPs, and DN2 cells 
showed severely decreased expansion in DLL1-Fc cultures in the presence of increased 
levels of SCF (Fig. 3E), suggesting that PRL2 mediates SCF/c-Kit signaling in early T cell 
progenitors. These data demonstrated that PRL2 is more important for early stage (c-Kit 
positive) than later stage T cell development.
Notch signaling regulates PRL2 expression during T cell differentiation
When we assessed PRL2 expression in purified KSLs, multipotent progenitors (MPPs), 
common lymphoid progenitors (CLPs), ETPs, DN2 and DN3 thymocytes by quantitative 
real-time PCR, we found that PRL2 was highly expressed in DN2 thymocytes (Fig. 4A), 
suggesting that PRL2 may be a downstream target of active Notch signaling. We then 
examined PRL2 expression following Delta ligand engagement. We plated purified LMPPs 
or DN2 cells on DLL1-Fc cultures and measured the change in PRL2 mRNA levels over 
time. PRL2 mRNA was upregulated during DLL1 mediated T cell differentiation but not by 
control IgG (Fig. 4B). We also found that ectopic expression of constitutive active Notch1, 
intracellular domain of Notch1 (Notch-ICN1), increased PRL2 protein levels in Prl2+/+ 
Lin−Sca-1+ cells (Fig. 4C). RBPJ/CSL transcription factor is the key mediator of Notch 
signaling in the thymus [1–2], and we found that both mouse and human PRL2 promoter 
regions have RBPJ/CSL and HES binding motifs (Supplementing information Fig. S5A). To 
determine whether RBPJ/CSL associates with the promoter regions of PRL2, we performed 
chromatin immunoprecipitation (ChIP) assays in a human T cell progenitor cell line Tail-7 
[24]. We found that RBPJ/CSL was associated with several regions of the PRL2 promoter 
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(Fig. 4D). Genome-wide ChIP-seq analysis also showed Notch binding to the PRL2 
(PTP4A2) locus in human T cell leukemia cell line CUTLL1 (Supplementing information 
Fig. S5B) [25]. In luciferase reporter assays, we found that Notch-ICN1 activated the PRL2 
promoter but not the PRL2 promoter containing mutations of CSL binding sites (Fig. 4E and 
Supplementing information Fig. S5C). These findings demonstrate that PRL2 is a direct 
target of Notch/RBPJ in T cell progenitors.
Notch/RBPJ pathway upregulates c-Kit expression in ETPs
Similar to PRL2 promoter, c-Kit promoter has multiple putative RBPJ/CSL and HES 
binding sites (Supplementing information Fig. S6A), suggesting that Notch/RBPJ pathway 
may regulate c-Kit expression in T cell progenitors. We observed increased fluorescent 
intensity of c-Kit in LMPPs treated with DLL1-Fc compared with cells treated with IgG 
(Fig. 5A). We then examined the kinetics of c-Kit transcription following Delta/Notch 
engagement and found that DLL1-Fc increased the level of c-Kit mRNAs, which was 
maintained for several days (Fig. 5B). Consistent with this observation, we found that 
Lin−Sca-1+ cells expressing Notch-ICN1 showed increased level of c-Kit proteins compared 
to control cells (Fig. 5C). To determine whether upregulation of c-Kit was mediated by 
Notch/RBPJ pathway, we examined c-Kit expression in RBPJ-deficient T cell progenitors 
[26]. When we evaluated RBPJfl/flCre+ mice 18 days after pI:pC injection, we found that the 
fluorescent intensity of c-Kit was markedly reduced in ETPs of the RBPJfl/flCre+(KO) 
thymus compared to that of the RBPJfl/flCre− (WT) thymus (Fig. 5D). Interestingly, we 
detected very few c-Kit+ DN2 cells in the RBPJ KO thymus (Supplementing information 
Fig. S6B). In addition, KSLs and HSC-enriched populations (CD48−KSLs) isolated from the 
RBPJ KO BM showed decreased fluorescent intensity of c-Kit compared to that of the RBPJ 
WT BM cells (Fig. 5E). To determine whether RBPJ/CSL associates with the promoter 
regions of KIT, we performed chromatin immunoprecipitation (ChIP) assays in Tail-7 cells 
and found no association of RBPJ with KIT promoter (data not shown). Genome-wide ChIP-
seq analysis in CUTLL1 cells did not show Notch binding to KIT promoter (Supplementing 
information Fig. S6C) [25], suggesting that Notch/RBPJ may indirectly regulate KIT 
expression in T cell progenitors. To determine whether increased c-Kit expression was 
specific to the Delta/Notch engagement in the thymic environment, we compared the 
abilities of DLL1-Fc and Jagged1-Fc (Jag1) to drive c-Kit expression in LMPP cells [26]. 
Sorted LMPPs were cultured with control IgG, DLL1-Fc, or Jag1-Fc. While DN2/3 cells 
were efficiently produced from DLL1-treated WT LMPPs, only low numbers of DN2/3 cells 
were generated from Jag1-treated WT LMPPs (Fig. 5F). Importantly, we found that RBPJ 
KO LMPPs failed to maintain high c-Kit expression by any stimulation (Fig. 5F) and that 
level of c-Kit mRNAs was decreased in RBPJ KO LMPPs regardless of any ligand (Fig. 
5G). These findings indicate both Delta (Thymic environmental factor) and Jagged (BM 
environmental factor) ligands utilize the canonical Notch/RBPJ pathway to upregulate 
and/or maintain c-Kit expression for the appropriate cell differentiation program.
PRL2 sustains Notch-mediated c-Kit expression in T cell progenitors
Given that dysfunctional c-Kit signaling impaired T cell differentiation, we measured c-Kit 
intensity in DN1 cells using OP9-DL1 cultures. While most cells within the Prl2+/+ DN1 
population were c-Kitbright ETPs, more than half of the Prl2−/− DN1 cells failed to maintain 
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high c-Kit expression (Fig. 6A). A similar phenotype was observed in DLL1-Fc cultures. 
Notably, c-Kit mRNA was upregulated in freshly isolated Prl2−/− LMPPs and in subsequent 
cultures (Supplementing information Fig. S7A and S7B), suggesting that decreased c-Kit 
protein seen in Prl2−/− T cell progenitors may be due to accelerated turnover. We also found 
that the primary Prl2−/− thymus had lower level of c-Kit protein compared to the Prl2+/+ 
thymus (Figure 6B), ruling out potential artifacts caused by cell cultures. Notably, Prl2−/− 
LMPPs treated with DLL1 differentiated into myeloid cells (Fig. 6C), demonstrating that 
PRL2 deficiency and low level of SCF have similar impact on T cell progenitor 
differentiation (Supplementing information Fig. S3A). Consistent with these findings, sorted 
Prl2−/− ETPs retained myeloid colony forming capabilities (Fig. 6D). To determine the 
impact of PRL2 on KIT activation, we stimulated Prl2+/+ and Prl2−/− hematopoietic 
progenitor cells with SCF and monitored KIT phosphorylation over time. We found that 
Prl2−/− hematopoietic progenitor cells showed decreased KIT phosphorylation at tyrosine 
703 compared to Prl2+/+ cells following SCF stimulation (Fig. 6E). In addition, we found 
that PRL2 was associated with KIT in 293 cells (Fig. 6F). These data demonstrate that PRL2 
is a key modulator of KIT signaling.
To understand the molecular basis of PRL2 deficiency on T cell differentiation, we 
performed gene expression profiling assays using sorted ETPs. Interestingly, we found that 
Tcf-1 and Bcl-2 mRNAs were decreased in Prl2−/− ETPs compared to Prl2+/+ ETPs. Several 
Notch downstream targets, including Hes1 and Fbxw7, were modestly increased in Prl2−/− 
ETPs (Supplementing information Fig. S7C). We also observed increased levels of Cebpα in 
Prl2−/− ETPs and LMPPs compared to Prl2+/+ cells (Supplementing information Fig. S7D). 
Although Prl2−/− DN1 cells did not exhibit enhanced apoptosis in steady state, Prl2−/− ETPs 
harvested from OP9-DL1 cultures showed increased apoptosis (Supplementing information 
Fig. S8A and S8B), indicating that PRL2 affects ETP expansion and survival after in vitro 
cultures. Thus, sustaining high level of c-Kit expression by PRL2 is crucial for ETP 
expansion, survival, and commitment during early stage T cell development (Fig. 7).
DISCUSSION
Notch signals provided by the thymic environment are critical for ETP maintenance and T 
cell differentiation [1–2]. One of the unique features of ETPs is the expression of high levels 
of c-Kit [1]. However, whether Notch signals link to c-Kit expression remains elusive. While 
one previous study showed a possible connection between Notch and c-Kit expression in B 
cell biased progenitors [14], recent studies indicate that BM derived LMPPs are the major 
source of ETPs [27–28]. Thus, it is important to investigate c-Kit regulation at LMPP and 
ETP stages in order to clarify this outstanding question. We found that canonical Notch 
signaling-mediated c-Kit expression is critical for early T cell differentiation, underscoring 
the importance of the c-Kit “bright” phenotype of ETPs. Further, we demonstrate that PRL2 
participates in this process by sustaining Notch-driven c-Kit signaling activity. Thus, the 
Notch/RBPJ pathway regulates early T cell development, at least in part, through 
upregulating PRL2 and c-Kit expression as well as sustaining higher c-Kit activity (Fig. 7).
SCF/c-Kit signaling is important for T cell differentiation. In fact, c-Kit bright DN1 cells can 
produce more T cells than c-Kit low DN1 cells [24]. One of the important findings in the 
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various c-Kit LOF mutant mice strains is that T cell defects are more dramatic than the 
defects of the other lineages [11–12]. Given that hematopoietic defects seen in the c-Kit 
mutant mice may be due to a cumulative effect from HSCs to progenitors in all lineages [5–
8], it has been difficult to specify which stage of T cell development requires c-Kit 
expression. Our work indicates that there is a “functional window” for c-Kit dependency at 
the ETP stage and that Delta/Notch engagement is essential for c-Kit upregulation. Our data 
provide new evidence that Delta/Notch engagement in the thymus drives higher c-Kit 
expression in early T cell progenitors and promotes T cell differentiation.
Recent studies have shown that HSCs that express an intermediate level of c-Kit and HSCs 
that express a high level of c-Kit (c-Kithigh) had distinct self-renewal capability, indicating 
that c-Kit surface expression and activity are tightly regulated in HSCs to ensure the proper 
balance between self-renewal and terminal differentiation [29–30]. While the heterozygous 
c-KitW/+ mutant mice had no or modest hematopoietic defects in steady state, HSC self-
renewal was dramatically impaired following transplantation of c-Kit mutant cells into 
lethally-irradiated recipient mice [13], suggesting that the effect of reduced c-Kit expression 
and activity on HSCs is more profound under stress conditions. Therefore, our observations 
that show differences between homeostatic and stress T cell development in PRL2 null mice 
are consistent with these reports. These findings also suggest that appropriate levels of c-Kit 
can be maintained in different tissues. It is important to maintain low levels of c-Kit in the 
BM to enhance HSC self-renewal, whereas sustaining high levels of c-Kit in the thymus 
facilitates the effective DN1-to-DN2 transition.
While Jagged-1/Notch2 association plays certain roles in postnatal HSC maintenance [31–
32], the canonical Notch1/RBPJ pathway is dispensable for adult HSC function [26, 33]. In 
fact, either Jagged-1 or Notch2 mutation results in multiple musculoskeletal and liver 
abnormalities, but none of these mutations affects T cells [34]. However, we found that both 
DLL1/Notch1 and Jag1/Notch2 utilized the canonical Notch/RBPJ pathway to regulate c-Kit 
expression in T cell progenitors. While both Jagged-1 and DLL1 can induce c-Kit 
expression [31], it is not clear why Jagged-1/Notch2 showed decreased T cell potential 
compared with DLL1/Notch1. It could be due to multiple factors, including differences in 
ligand density between thymic Delta-like 4 and Jagged in the BM niche [23, 35], different 
signaling [36–37], or differential regulators, such as lunatic fringe, which modulates Delta/
Notch specificity [38].
We found that c-Kit mRNA was upregulated in freshly isolated Prl2−/− LMPPs whereas the 
fluorescence intensity of c-Kit in Prl2−/− LMPPs was decreased, suggesting that PRL2 may 
regulate c-Kit turnover in T cell progenitors. PRL2 deficient cells and c-KitY823F mutant 
cells appear to share similar features, including increased c-Kit turnover and inability to 
sustain c-Kit activity [39]. Given that the c-KitY823F mutant affects cell survival [39], the 
enhanced apoptosis of PRL2 null ETPs in OP9-DL1 culture may, at least in part, be due to 
inappropriate function of the second TK under higher demand of c-Kit activity.
PRLs are highly expressed in human cancer cells, including ovarian, lung, breast and liver 
cancers [15–17]. Recent findings suggest that PRLs may play important roles in the 
pathogenesis of hematological malignancies [19]. PRL3 is highly expressed in BCR-ABL 
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positive acute lymphoblastic leukemia (ALL), which may be responsible for the aggressive 
phenotype of the disease [40]. PRL2 is located on human chromosome 1p35, a region often 
rearranged or amplified in malignant lymphoma and B-cell chronic lymphocytic leukemia 
(B-CLL) [41]. The leukemia initiating cells (LICs) in the Notch-ICN1 induced leukemia 
were recently characterized as c-Kit+ cells [42]. We found that expression of Notch-ICN1 in 
Lin−Sca1+ cells upregulated c-Kit and sustained DN2 cells without stromal support. 
However, PRL2 null cells expressing Notch-ICN1 failed to maintain DN2 cells. Recently, 
we reported that PRL2 plays a critical role in the pathogenesis of T-ALL [43]. We 
discovered that genetic and pharmacological inhibition of PRL2 impaired the proliferation 
and survival of human T-ALL cells in vitro and deletion of PRL2 inhibited the initiation and 
maintenance of oncogenic NOTCH1-induced T-ALL development in vivo. Mechanistically, 
NOTCH1 signaling upregulated PRL2 to maintain the leukemogenic potential of c-Kit+ 
leukemia initiating cells [43]. Our data suggest that PRL2 is important for DN1-DN2 
transition during normal T cell development but maintains c-Kit+ LICs to promote the 
pathogenesis of T-ALL.
CONCLUSIONS
Delta/Notch engagement induces the expression of both PRL2 and c-Kit in ETPs. PRL2 
sustains and/or potentiates Kit signaling to facilitate DN1-DN2 transition. In the absence of 
PRL2, c-Kit expression is decreased. Decreased c-Kit expression promotes ETP 
differentiation toward myeloid lineages. Thus, sustaining high level of c-Kit expression by 
PRL2 is crucial for ETP expansion, survival and commitment during early stage T cell 
development (Fig. 7).
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Figure 1. Prl2−/− mice have moderate T cell defects in steady state
(A) Splenocytes and thymocytes from 8-week-old Prl2+/+ and Prl2−/− mice were isolated 
and counted. Absolute splenocyte and thymocyte numbers from Prl2−/− mice are reduced to 
50% of Prl2+/+ mice. ***P<0.001, n=10. (B) Analysis of CD4+, CD8+, DP, and DN 
thymocytes in Prl2+/+ and Prl2−/− mice by flow cytometry. The frequency of DN cells is 
increased in Prl2−/− thymus compared to Prl2+/+ thymus. **P<0.01, n=7. (C) Analysis of 
DN1, ETP, DN2, DN3, DN4 and DP thymocytes in Prl2+/+ and Prl2−/− mice by flow 
cytometry. Absolute number of DN4 and DP cells is decreased in Prl2−/− thymus compared 
to Prl2+/+ thymus. **P<0.01, n=7. (D) Steady state cell cycle status of thymocytes was 
determined by Ki67 and DAPI staining. The percentage of cells at the G0 phase of the cell 
cycle was shown. Percentage of quiescent (G0) Prl2−/− DN2a and DN2b thymocytes is 
slightly increased compared to Prl2+/+ cells. *P<0.05, n=6. (E) Staining for Annexin V and 
propidium iodide (PI) in thymocytes isolated from Prl2+/+ and Prl2−/− mice after 48 h 
culture in serum-free medium, in the presence or the absence of irradiation (2Gy).
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Figure 2. PRL2 deficiency impairs T cell development following hematopoietic stem cell 
transplantation
(A) The frequency of donor-derived cells in spleen, thymus, and bone marrow of recipient 
mice was determined 18 weeks following bone marrow transplantation. Prl2−/− cells show 
decreased engraftment in thymus compared to Prl2+/+ cells. (B) The frequency of donor-
derived cells in the peripheral blood (PB) of recipient mice was determined every 4 weeks 
following transplant Prl2+/+ or Prl2−/− HSCs into lethally-irradiated recipient mice. CD3+ T 
cell recovery was significantly lower in recipients repopulated with Prl2−/− HSCs than that 
of the Prl2+/+ HSCs. (C) Absolute number of donor derived LT-HSCs in 2 femurs (left 
panel). Absolute number of PB T cells generated from Prl2−/− HSCs was remarkably 
reduced compared with that of the Prl2+/+ HSCs. (D) Achievement of donor-derived 
chimerism in each differentiation stage at 16 weeks after transplantation is shown. (E) 
Representative flow cytometry plot of donor-derived ETPs. Number indicated the percentage 
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of ETPs in total CD45.2 positive cells. (F) The frequency of different T cell population in 
donor-derived cells is shown (***P<0.001, **P<0.01, n=8).
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Figure 3. PRL2 deficiency impairs T cell development in vitro
(A and B) Purified Prl2+/+ and Prl2−/− KSL cells were cultured on DL-OP9 cells in the 
presence of IL-7. Cells were then harvested at different time point and stained with various 
markers to measure T cell differentiation. Prl2−/− KSLs show marked reduction of 
cumulative total cell count (A) and double positive T cell count (B) compared with Prl2+/+ 
cells. (C and D) To determine stage specificity, sorted KSLs and DN3 were cultured on OP-
DL1 cells for 8 days or 15 days, respectively. Production of ETPs from KSLs and production 
of total nucleated cells (TNCs) from DN3 cells were calculated. Prl2−/− cells show profound 
expansion defects at early stage (C) than that of the later stage (D). (E) Sorted LMPPs, 
ETPs, or DN2 cells were cultured on DLL1-Fc coated plate in the presence of graded dose 
of SCF. Total cell count was determined at day 12. Prl2−/− cells show defective expansion 
compared with Prl2+/+ cells, even in the presence of high dose of SCF.
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Figure 4. Notch signaling regulates PRL2 expression during T cell differentiation
(A) Quantitative real-time PCR analysis of PRL2 expression in sorted MPPs, CLPs, ETPs, 
DN2, DN3, DN4, DP, and CD4+ thymocytes, presented relative to expression in KSLs, set 
as 1. PRL2 is highly expressed in DN2 cells. n = three biological replicates. (B) Sorted 
Prl2+/+ LMPPs were cultured in the presence or the absence of DLL1-Fc. Cells were 
collected at each time point and PRL2 expression was determined by quantitative real-time 
PCR analysis. **P<0.01, n = three biological replicates. (C) Notch-ICN1 was introduced 
into Prl2+/+ Lin−Sca1+ cells and the levels of PRL2 protein were determined by western blot 
analysis. (D) Chromatin-bound DNAs from Tail-7 cells were immunoprecipitated with a 
RBPJ-antibody or normal mouse IgG. Quantitative real-time PCR amplification was 
performed on corresponding templates using primers for PRL2 gene. (E) Notch-ICN1 
transactivates PRL2 promoter. 293 cells were transfected with PRL2 promoter driven 
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luciferase reporter plasmids containing either RBPJ binding sites or mutant RBPJ binding 
sites. Luciferase activity was assayed 24 hours after transfection. *P<0.05, n=3.
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Figure 5. PRL2 sustains Notch mediated c-Kit expression in T cell progenitors
(A) Expression of c-Kit was induced by DLL1-Fc during T cell differentiation, assessed by 
flow cytometry. (B) Sorted Prl2+/+ LMPPs and DN2 cells were cultured in the presence or 
the absence of DLL1-Fc. Cells were collected at each time point and c-Kit expression was 
determined by quantitative real-time PCR analysis, presented relative to expression in sorted 
LMPPs. **P<0.01, n = three biological replicates. (C) Notch-ICN1 was introduced into wild 
type Lin−Sca1+ cells and the levels of c-Kit protein were determined by western blot 
analysis. (D, E) Flow cytometry analysis of c-Kit expression in primary RBPJ-KO thymus 
(D) or BM (E) at 3 weeks post pI:pC injection. The mean fluorescent intensity (MFI) of c-
Kit was greatly reduced in RBPJ-deficient cells compared with that of the WT cells. (F) T 
cell induction from RBPJ-KO or WT LMPPs. Sorted LMPPs were cultured with control 
IgG, DLL1, or Jag1. The MFI of c-Kit was measured at day 7. (G) Kinetic study of c-Kit 
expression in T cell cultures of LMPPs isolated from WT and RBPJ-KO mice. Relative c-
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Kit mRNA levels were measured by quantitative real-time PCR analysis. **P<0.01, n = 
three biological replicates.
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Figure 6. PRL2 sustains Notch-mediated c-Kit expression in T cell progenitors
(A) Expression of c-Kit in DN1-gated Prl2+/+ and Prl2−/− cells in OP9-DL1 cultures, 
assessed by flow cytometry. Right panels show the mean fluorescent intensity (MFI) of c-Kit 
in DN1 cells. **P<0.01, n=3. (B) Expression of c-Kit in DN1 thymocytes isolated from 
Prl2+/+ and Prl2−/− mice, assessed by flow cytometry. Right panels show the mean 
fluorescent intensity (MFI) of c-Kit in ETP gated thymocytes. **P<0.01, n=10. (C) Myeloid 
differentiation was evaluated in DLL1 cultures of LMPPs. Prl2−/− LMPPs differentiated into 
CD11b+/Gr1+ myeloid cells at day 16 (0.5±0.3 vs 11.5±4.1 %, **P<0.01, n=3). (D) Myeloid 
progenitors were quantified by methylcellulose culture using ETPs from Prl2+/+ and Prl2−/− 
mice. (E) PRL2 is important for KIT activation following SCF stimulation. Immunoblot 
analysis of KIT phosphorylation in WT and Prl2 null hematopoietic progenitor cells 
following SCF stimulation. (F) PRL2 interacts with KIT in 293 cells.
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Figure 7. Protein tyrosine phosphatase PRL2 mediates Notch and Kit signals in early T cell 
progenitors
(A) Working model. Cooperation of PRL2 phosphatase with Notch and c-Kit signals is 
critical for early T cell differentiation. Delta/Notch engagement induces the expression of 
both c-Kit and PRL2 in ETPs. PRL2 then sustains and/or potentiates Kit signaling to 
facilitate DN1-DN2 transition. In the absence of PRL2, c-Kit expression is decreased and 
decreased c-Kit expression promotes ETP differentiation toward myeloid lineages. Thus, 
sustaining high level of c-Kit expression by PRL2 is crucial for ETP expansion, survival, 
and commitment during early stage T cell development.
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